UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000032671 |
|---|---|
| Receipt number | R000037132 |
| Scientific Title | Phase Ib study of combination therapy with Cisplatin, Irinotecan, and Ramucirumab for extensive-disease small-cell lung cancer |
| Date of disclosure of the study information | 2018/05/22 |
| Last modified on | 2021/05/24 13:08:35 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/05/22 09:59:45 | ||
| 2 | Update | 2018/05/23 00:05:21 | Recruitment status |
|
| 3 | Update | 2018/11/21 10:55:52 | Name of person sending information Name of person sending information TEL |
|
| 4 | Update | 2020/05/23 13:34:49 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2020/05/23 13:36:38 | Number of participants that the trial has enrolled |
|
| 6 | Update | 2020/05/23 14:07:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of person sending information Organization Division name Division name TEL Organization Organization Address Address Tel |
|
| 7 | Update | 2020/06/03 11:53:02 | Key exclusion criteria Key exclusion criteria |
|
| 8 | Update | 2021/05/24 13:08:35 | Recruitment status |
